
J&J to Pay $2.2 Billion in Criminal/Civil Fines over Antipsychotic Drug Risperdal & 2 other drugs
The New York Times – November 4, 2013 By Katie Thomas Johnson & Johnson has agreed to pay $2.2 billion in criminal and civil fines…
The New York Times – November 4, 2013 By Katie Thomas Johnson & Johnson has agreed to pay $2.2 billion in criminal and civil fines…
Big Pharma firm Johnson & Johnson, maker of the antipsychotic drug Risperdal, owes hundreds of millions of dollars to several states over improper marketing of the medication and for encouraging doctors to prescribe it for non-approved uses, but because the case was settled in court the company’s CEO, Alex Gorsky, won’t have to testify about allegations his company’s drug caused some young boys to grow breasts, among others.
Big Pharma firm Johnson & Johnson, maker of the antipsychotic drug Risperdal, owes hundreds of millions of dollars to several states over improper marketing of the medication and for encouraging doctors to prescribe it for non-approved uses, but because the case was settled in court the company’s CEO, Alex Gorsky, won’t have to testify about allegations his company’s drug caused some young boys to grow breasts, among others.